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ABSTRACT 
 
The molecular responses of macrophages to copper-based nanoparticles has been 
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investigated by a combination of proteomic and biochemical approaches, using the 
RAW264.7 cell line as a model. Both metallic copper and copper oxide nanoparticles 
have been tested, with copper ion and zirconium oxide nanoparticles as controls. 
Proteomic analysis highlighted changes in proteins implicated in oxidative stress 
responses (superoxide dismutases and peroxiredoxins), in glutathione biosynthesis, in 
the actomyosin cytoskeleton and in mitochondrial proteins (especially oxidative 
phosphorylation complex subunits). Validation studies by functional analyses showed 
that the increase in glutathione biosynthesis and in mitochondrial complexes observed in 
the proteomic screen was critical to cell survival upon stress with copper-based 
nanoparticles; pharmacological inhibition of these two pathways enhanced cell 
vulnerability to  copper-based nanoparticles but not to copper ion. Furthermore, 
functional analyses using primary macrophages derived from bone marrow showed a 
decrease in reduced glutathione levels, a decrease in the mitochondrial transmembrane 
potential, as well as an inhibition of phagocytosis and of lipopolysaccharide-induced 
nitric oxide production. However, only a fraction of these effects could be obtained with 
copper ions. In conclusion, this study showed that macrophage functions are 
significanlty altered by  copper-based nanoparticles. Also highlighted are the cellular 
pathways modulated by cells for survival and the exemplified cross-toxicities that can 
occur between copper-based nanoparticles and pharmacological agents. 
. 
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INTRODUCTION 
Manufactured nanoparticles are more and more widely used in more and more 
consumer products, ranging from personal care products to tyres and concrete. 
Among the nanoparticles, metals and metal oxides represent an important part of the 
total production and are used in water treatment, as antibacterials, in antifouling 
paints or in microelectronics. These wide uses pose in turn the problem of the 
toxicological evaluation of the toxicity of these nanoparticles (1, 2), and especially of 
the long-term effects that often do not come from simple cell mortality but from 
altered cellular functions. 
Macrophages are one of the cell types that deserve special attention in toxicology, 
due to the variety of their functions. An altered cytokine production can lead to 
adverse long term effects, as documented for example in the case of asbestos (3). 
Other dysfunctions of the innate immune system can lead to deregulation of the 
immune responses and to severe adverse effects, e.g. a higher incidence of tumours 
(4).  
It is therefore not surprising that immunotoxicology of nanoparticles is a developing 
field (5-7), and several studies have been devoted to the response of macrophages 
to nanoparticles. However, most of these studies are limited to the effect of 
nanoparticles on cell viability and on cytokine production (e.g. (8-11)) although some 
publications also study oxidative stress (12-14) and sometimes other functional 
parameters (15-17) . Very few studies use the analytical power of proteomics to go 
deeper into the mechanisms of response to nanoparticles or to metals (reviewed in 
(18)).  A few exceptions exist, e.g. on carbon-based nanoparticles (19) and on 
titanium dioxide  (20, 21). 
 
Most of the toxicological studies in this field have been focused on a few 
nanoparticles, either used as health products such as iron oxide (15, 17, 22), or used 
in variety of consumer products such as silver  (13, 14), silica (9, 12) or titanium 
dioxide (11, 16, 20, 21). 
 
However, many other nanoparticles are more and more used in industrial 
applications without extensive toxicological testing. Good examples are indium-tin 
oxide, used in electronic screens and which appears to be toxic (23) 
and the copper-based nanoparticles, used in high-performance batteries (24), in 
water depollution (25), and as bactericidal in replacement of nano-silver. Copper and 
copper oxide induce a strong toxicity (26, 27), coupled with inflammation (28), 
oxidative stress (29) and genotoxicity (30), at least in epithelial cells.  
In the light of these various effects, we have decided to use a combination of a 
proteomics approach with targeted approaches to address in more molecular details 
the responses of macrophages to copper-based nanoparticles, i.e. both metallic 
copper and copper II oxide.  
 
MATERIAL AND METHODS 
 
Nanoparticles  
 
Metallic copper and copper oxide nanoparticles (<50 nm) were purchased from 
Sigma-Aldrich (catalog numbers 684007 and 544868 respectively). They were 
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dispersed in water as a 5.5% w/v suspension  by sonication for 60 minutes in a cup-
horn instrument (BioBlock Scientific, France) , under a 5°C thermostated water 
circulation.  One-tenth volume of 10% w/v PVP40 solution was added under sterile 
conditions, and the particles were coated for 1 hour under constant agitation. The 
actual size of the particles was determined after dilution in water or in complete 
culture medium by dynamic light scattering, using a Wyatt Dynapro Nanostar 
instrument or a Malvern HS 3000 instrument, the latter instrument being also used to 
determine the zeta potential.  
The morphology of the samples was observed by SEM (Scanning Electron 
Microscopy). A 200 mesh carbon grid was dipped in the nanoparticles suspensions 
and dried under air before imaging. 
The amount of coating attached on the inorganic nanoparticles was evaluated from 
weight loss (from about 10mg of sample) after annealing under air using a 
Thermogravimetric Analysis device (Setaram). The temperature cycle was heating at 
a rate of 10°C/min up to 600°C followed by a dwelling time of 30 minutes and natural 
cooling.  
Zirconium oxide nanoparticles (<100 nm) were purchased from Sigma-Aldrich as a 
10% (w/v) dispersion  in water (catalog number 643025). Prior to use, they were 
diluted by mixing one volume of dispersion with one volume of 2% w/v PVP-40 for 1 
hour under constant agitation. The actual size of the final dispersion in complete 
culture medium was determined as for the copper nanoparticles.  
 
 
Nanoparticles dissolution in culture medium 
 
Nanoparticles were added at 5, 10 or 20 µg/ml to complete culture medium (RPMI 
1640 + 10% fetal bovine serum) in cell culture 6 well plates containing 2ml culture 
medium per well. In some experiments, conditioned medium, i.e. complete cell 
culture medium having been in contact with the cells for at least 24 hours, was used 
in place of fresh complete culture medium. Known concentrations of copper chloride 
were also added to complete culture medium in control wells and incubated under 
the same conditions. The plates were incubated for 24 hours in a cell culture 
incubator at 37°C and 5% CO2 atmosphere. The culture medium was recovered, 
and centrifuged at 270,000g for 45 minutes to sediment the nanoparticles (31). The 
concentration of copper ions was then determined using the Zincon method (32). 
Briefly, 1 ml of supernatant was acidified with trichloroacetic acid (7.5% w/v final 
concentration) to precipitate proteins and release bound copper ions. This 
precipitation step was carried out for 30 minutes on ice. The precipitated proteins 
were eliminated by centrifugation (15,000 g, 15 minutes), and the supernatants were 
collected. After neutralization by addition of 0.3 volumes of 2 M Tris, Zincon was 
added (50 µM final concentration) and the copper concentration was determined by 
absorbance at 600 nm, using the copper chloride in medium points to build the 
standard curve.  
 
Cell culture 
 
Cell lines 
 
The mouse macrophage cell line RAW 264.7 was obtained from the European Cell 
Culture Collection (Salisbury, UK). The cells were cultured in RPMI 1640 medium + 
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10% fetal bovine serum. Cells were seeded every two days at 200,000 cells/ml and 
harvested at 1,000,000 cells per ml. 
 
Primary macrophages 
 
Primary mouse macrophages were obtained from bone marrows essentially as 
described by Schleicher and Bogdan (33) and Tarakanova et al. (34) . Briefly, bone 
marrow was aseptically collected from femur and tibias of 4 weeks-old C57Bl6 mice, 
sacrificed by cervical dislocation. The marrow plugs were dissociated by repeated 
flushing in the culture medium (DMEM 65% v/v, L929 cell culture supernatant 20% 
v/v, fetal bovine serum 10% v/v and horse serum 5% v/v) and plated at 4 million 
cells/ml on bacteriology culture dishes. An equal volume of medium was added after 
4 days in culture. After 7 days of culture, the cells were scraped and replated at 1 
million cells/ml in the same medium, except that the L929 supernatant was lowered 
to 10% v/v and DMEM increased to 75% v/v. Mature macrophages were obtained 
after an additional 3 days, and were viable and stable up to 2 weeks, provided that 
the culture medium was renewed every 3 days.  
 
Cell treatment and viability assessment 
 
Cells were treated with variable concentrations of nanoparticles, added directly in the 
culture medium. After 24 hours in the presence of the nanoparticles or ions, cell 
viability was measured by trypan blue exclusion. For treatment with inhibitors, cells 
were pretreated for 6 hours with either 100µM buthionine sulfoximine or 200 nM 
rotenone or 200 nM antimycin A. Copper oxide nanoparticles (or copper chloride) 
were then added for a further 18 hours before collection of the cells and viability 
measurements.  
 
Neutral red uptake assay 
 
This assay was performed essentially as described in (35). Briefly, cells grown in 12-
well plates and treated or not with nanoparticles were incubated for 1 hour with 40 
µg/ml neutral red (final concentration, added from a 100x stock solution in 50% 
ethanol water). At the end of the incubation period, the medium was discarded and 
the cell layer was rinsed twice with PBS (5 minutes per rinse). The PBS was 
removed, and 1 ml of elution solution (50% ethanol and 1% acetic acid in water) was 
added per well. The dye was eluted for 15 minutes under constant agitation, and the 
dye concentration was read spectrophotometrically at 540 nm. The results were 
expressed as % of the control cells (untreated with nanoparticles).  
 
Phagocytosis activity measurement 
 
The phagocytic acitivity was measured using fluorescent latex beads (1µm diameter, 
green labelled, catalog number L4655 from Sigma), essentially as described in (36). 
Briefly, the beads were pre-incubated at a final concentration of 55 mg/ml  for 30 
minutes at 37°C in a 1:1 (v/v)  PBS/ horse serum solution. They were then incubated 
with the cells (5.5 mg/L final concentration) for 2 h at 37°C. The cells were then 
harvested, washed twice with cold PBS, and incubated for 5 minutes on ice with a 
0.25 M D-sorbitol solution in order to remove beads adhering to the cell surface. 
After another wash with cold PBS, cells were analyzed by flow cytometry on a 
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FACScalibur instrument (Beckton Dickinson), using fluorescein excitation/emission 
filters, and using the live cell selection as described above. 
 
Transmission Electron Microscopy 
 
For TEM, fixation was initiated by adding an equal volume of fixative solution, 
previously warmed to 37°C, to the cells after treatment with copper oxide 
nanoparticles for 24 hours. The fixative solution contained 5% glutaraldehyde 
(Electron Microscopy Sciences, Euromedex, Strasbourg, France) in a 0.1 M sodium 
cacodylate buffer (both Merck, Darmstadt, Germany) (305 mOsm, pH 7.3). After 10 
min the mixture was centrifuged, the supernatant was discarded, and the pellet 
resuspended in the fixative solution containing 2.5% glutaraldehyde in 0.1 M sodium 
cacodylate buffer for 45 min at room temperature. The cells were then washed in 0.1 
M sodium cacodylate buffer and postfixed for 1 h at 4°C with 1% osmium tetroxide 
(Merck) in the same buffer and stained for 1 h at 4°C in 4% uranyl acetate. After 
further washing in distiled water, the cells were dehydrated in graded (50, 70, 80, 95, 
and 100%) ethanol solutions, incubated for 1 h in Epon (Electron Microscopy 
Sciences): absolute alcohol (1:1, vol/vol), then overnight in Epon and embedded in 
Epon. Ultrathin sections, stained with lead citrate (Leica, Bron, France) and uranyl 
acetate (Merck), were examined under a Philips CM 120 BioTwin electron 
microscope (120 kV). 
 
 
Intracellular glutathione measurements 
 
Intracellular glutathione levels were analyzed by the monochlorobimane technique  
(37), with some modifications (38). Briefly, the cells were harvested, centrifuged for 5 
minutes and then labelled for 5 minutes with a 50 µM monochlorobimane solution 
diluted in PBS at 37°C. The reaction was stopped for 5 minutes on ice in the dark, 
and the cells were then washed twice with cold PBS. Finally, the cells were analyzed 
by flow cytometry on a MoFlo instrument (Beckman Coulter) using a UV laser for 
excitation and reading the emission at 450 nm. The analysis was restricted to live 
cells only. 
 
Mitochondrial transmembrane potential assessment 
 
The mitochondrial transmembrane potential was assessed by Rhodamine 123 
uptake  (39). Briefly, cells were treated with 10 µg/ml Rhodamine 123 in complete 
culture medium for 30 minutes at 37 °C. Cells were then harvested, rinsed twice in 
cold PBS and analysed by flow cytometry on a FACScalibur instrument (Beckton 
Dickinson), using fluorescein excitation/emission filters. First the live cells were 
selected on the basis of the size and granularity, then the fluorescence of these live 
cells was measured using the fluorescein channel. 
 
NO production 
 
The cells were grown to confluence in a 6 well plate, and then treated or not with 
copper nanoparticles, copper oxide nanoparticles, or copper chloride. After 24 hours 
of treatment, half of the wells were treated with 1 µg/ml LPS (from salmonella), and 
arginine monohydrochloride was added to all the wells (5 mM final concentration) to 
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give a high concentration of substrate for the nitric oxide synthases. After 24 hours of 
incubation, the cell culture medium was recovered, centrifuged at 10,000 g for 10 
minutes to remove cells and debris, and the nitrite concentration was read at 540 nm 
after addition of an equal volume of Griess reagent and incubation at room 
temperature for 30 minutes 
 
Proteomics 
 
2D gel electrophoresis 
 
Sample preparation 
 
The cells were collected by scraping, and then washed three times in PBS. The cells 
were then washed once in TSE buffer (Tris-HCl 10 mM pH 7.5, sucrose 0.25M, 
EDTA 1 mM), and the volume of the cell pellet was estimated. The pellet was 
resuspended in its own volume of TSE buffer. Then 4 volumes (respective to the cell 
suspension just prepared) of concentrated lysis buffer (urea 8.75 M, thiourea 2.5 M, 
CHAPS 5% w/v, TCEP-HCl, 6.25 mM, spermine base 12.5 mM) were added and the 
solution was let to extract at room temperature for 1 hour. The nucleic acids were 
then pelleted by ultracentrifugation (270,000 g at room temperature for 1 h), and the 
protein concentration in the supernatant was determined by a dye-binding assay 
(40). Carrier ampholytes (Pharmalytes pH 3-10) were added to a final concentration 
of 0.4% (w/v), and the samples were kept frozen at -20°C until use 
 
Isoelectric focusing  
 
Home made 160 mm long 4-8 linear pH gradient gels (41) were cast according to 
published procedures (42).  Four mm-wide strips were cut, and rehydrated overnight 
with the sample, diluted in a final volume of 0.6 ml of rehydration solution (7 M urea, 2 M 
thiourea, 4% CHAPS, 0.4% carrier ampholytes (Pharmalytes 3-10) and 100mM 
dithiodiethanol (43)(44).  
The strips were then placed in a Multiphor plate (GE Healthcare), and IEF was carried 
out with the following electrical parameters: 100V for 1 hour, then 300V for 3 hours, then 
1000V for 1 hour, then 3400 V up to 60-70 kVh. After IEF, the gels were equilibrated for 
20 minutes in Tris 125mM, HCl 100mM, SDS 2.5%, glycerol 30% and urea 6 M (45) . 
They were then transferred on top of the SDS gels and sealed in place with 1% agarose 
dissolved in Tris 125mM, HCl 100mM, SDS 0.4% and 0.005% (w/v) bromophenol blue.  
 
SDS electrophoresis and protein detection 
 
Ten percent gels (160x200x1.5 mm) were used for protein separation. The Tris taurine 
buffer system (46) was used and operated at a ionic strength of 0.1 and a pH of 7.9. The 
final gel composition is thus Tris 180mM, HCl 100 mM, acrylamide 10% (w/v), 
bisacrylamide 0.27%. The upper electrode buffer is Tris 50 mM, Taurine 200 mM, SDS 
0.1%. The lower electrode buffer is Tris 50 mM, glycine 200 mM, SDS 0.1%. The gels 
were run at 25V for 1hour, then 12.5W per gel until the dye front has reached the bottom 
of the gel. Detection was carried out by fast silver staining (47).  
 
Image analysis 
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The gels were scanned after silver staining on a flatbed scanner ( Epson perfection 
V750), using a 16 bits grayscale image acquisition. The gel images were then analyzed 
using the Delta 2D software (v 3.6). 4 gels coming from 4 independent cultures were 
used for each experimental group. Spots that were never expressed above 100 ppm of 
the total spots were first filtered out. Then, significantly-vazrying spots were selected on 
the basis of their Student T-test p-value between the treated and the control groups. 
Spots showing a p-value lower than 0.05 were selected. However, two additional steps 
of statistical validation were used. On a global point perspective, the Storey and 
Tibshirani approach (48) was used to evaluate a FDR, as described previously (49). 
Then each of the selected spots was tested for significance by the Mann-Whitney 
ranking test, to rule out any bias that could exist the the T-test due to its underlying 
hypotheses.  
 
Mass spectrometry 
 
The spots selected for identification were excised from silver-stained gels and destained 
with ferricyanide/thiosulfate on the same day as silver staining in order to improve the 
efficiency of the identification process (50) (51). In gel digestion was performed with an 
automated protein digestion system, MassPrep Station (Waters, Milford, USA). The gel 
plugs were washed twice with 50 µL of 25 mM ammonium hydrogen carbonate 
(NH4HCO3) and 50 µL of acetonitrile. The cysteine residues were reduced by 50 µL of 
10 mM dithiothreitol at 57°C and alkylated by 50 µL of 55 mM iodoacetamide. After 
dehydration with acetonitrile, the proteins were cleaved in gel with 10 µL of 12.5 ng/µL of 
modified porcine trypsin (Promega, Madison, WI, USA) in 25 mM NH4HCO3. The 
digestion was performed overnight at room temperature. The generated peptides were 
extracted with 30 µL of 60% acetonitrile in 0.1% formic acid. Acetonitrile was evaporated 
under vacuum before nanoLC-MS/MS analysis. 
NanoLC-MS/MS analysis was performed using on nanoLC-QTOF-MS system and on 
nanoLC-IT-MS system. The nanoLC-QTOF-MS system was composed of the 
nanoACQUITY Ultra-Performance-LC (Waters Corporation, Milford, USA) coupled to the 
SynaptTM High Definition Mass SpectrometerTM (Waters Corporation, Milford, USA). The 
system was fully controlled by MassLynx 4.1 SCN639 (Waters Corporation, Milford, 
USA). 
The nanoLC system was composed of ACQUITY UPLC® BEH130 C18 column (250 
mm x 75 µm with a 1.7 µm particle size, Waters Corporation, Milford, USA) and a 
Symmetry C18 precolumn (20 mm × 180 µm with a 5 µm particle size, Waters 
Corporation, Milford, USA). The solvent system consisted of 0.1% formic acid in water 
(solvent A) and 0.1% formic acid in acetonitrile (solvent B). 4 µL of sample were loaded 
into the enrichment column during 3 min at 5 µL/min with 99% of solvent A and 1% of 
solvent B. Elution of the peptides was performed at a flow rate of 300 nL/min with a 8-
35% linear gradient of solvent B in 9 minutes.  
The tandem mass spectrometer was equipped with a Z-spray ion source and a lock 
mass system. The capillary voltage was set at 2.8 kV and the cone voltage at 35 V. 
Mass calibration of the TOF was achieved using fragment ions from Glu-fibrino-peptide 
B on the [50;2000] m/z range. Online correction of this calibration was performed with 
Glu-fibrino-peptide B as the lock-mass. The ion (M+2H)2+ at m/z 785.8426 was used to 
calibrate MS data and the fragment ion (M+H)+ at m/z 684.3469 was used to calibrate 
MS/MS data during the analysis. The system was operated in Data-Dependent-
Acquisition (DDA) mode with automatic switching between MS (0.5 s/scan on m/z range 
[150;1700]) and MS/MS modes (0.5 s/scan on m/z range [50;2000]). The two most 
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abundant peptides (intensity threshold 20 counts/s), preferably doubly and triply charged 
ions, were selected on each MS spectrum for further isolation and CID fragmentation 
using collision energy profile. Fragmentation was performed using argon as the collision 
gas.  
Mass data collected during analysis were processed and converted into .pkl files using 
ProteinLynx Global Server 2.3 (Waters Corporation, Milford, USA). Normal background 
subtraction type was used for both MS and MS/MS with 5% threshold and polynomial 
correction of order 5. Smoothing was performed on MS/MS spectra (Savitsky-Golay, 2 
iterations, window of 3 channels). Deisotoping was applied for both MS (medium 
desisotoping) and MS/MS (fast deisotoping). 
 
The nanoLC-IT-MS system was composed of the Agilent 1200 series nanoLC-Chip 
system (Agilent Technologies, Palo Alto, USA) coupled to the amaZon ion trap (Bruker 
Daltonics GmbH, Bremen, Germany). The system was fully controlled by HyStar 3.2 and 
trapControl 7.0 (Bruker Daltonics, Bremen, Germany). 
The chip was composed of a Zorbax 300SB-C18 (43 mm × 75 µm, with a 5µm particle 
size) analytical column and a Zorbax 300SB-C18 (40 nL, 5 µm) enrichment column. The 
solvent system consisted of 2% acetonitrile, 0.1% formic acid in water (solvent A) and 
2% water, 0.1% formic acid in acetonitrile (solvent B). 4 µL of sample were loaded into 
the enrichment column at a flow rate set to 3.75L/min with solvent A. Elution of the 
peptides was performed at a flow rate of 300 nL/min with a 8-40% linear gradient of 
solvent B in 7 minutes.  
For tandem MS experiments, the system was operated in Data-Dependent-Acquisition 
(DDA) mode with automatic switching between MS and MS/MS. The voltage applied to 
the capillary cap was optimized to -1850V. The MS scanning was performed in the 
standard enhanced resolution mode at a scan rate of 8100 m/z per second. The mass 
range was 250-1500 m/z. The Ion Charge Control was 200000 and the maximum 
accumulation time was 200 ms. A total of 2 scans was averaged to obtain a MS 
spectrum and the rolling average was 1. The six most abundant precursor ions with an 
isolation width of 4 m/z were selected on each MS spectrum for further isolation and 
fragmentation. The MS/MS scanning was performed in the ultrascan mode at a scan 
rate of 32500 m/z per second. The mass range was 100-2000 m/z. The Ion Charge 
Control was 300000. A total of 2 scans was averaged to obtain an MS/MS spectrum.  
Mass data collected during analysis were processed and converted into .mgf files using 
DataAnalysis 4.0 (Bruker Daltonics GmbH, Bremen, Germany). A maximum number of 
1700 compounds was detected with an intensity threshold of 150000. A charge 
deconvolution was applied on the MS full scan and the MS/MS spectra with an 
abundance cutoff of 5% and 2% respectively and with a maximum charge state of 3 and 
2 respectively.  
For protein identification, the MS/MS data were interpreted using a local Mascot server 
with MASCOT 2.4.0 algorithm (Matrix Science, London, UK) against 
UniProtKB/SwissProt (version 2012_08, 537,505 sequences). The research was carried 
out in all species. A maximum of one trypsin missed cleavage was allowed. Spectra 
from Qtof were searched with a mass tolerance of 15 ppm for MS and 0.05 Da for 
MS/MS data and spectra from Ion Trap were searched with a mass tolerance of 0.3 Da 
in MS and MS/MS modes. Carbamidomethylation of cysteine residues and oxidation of 
methionine residues were specified as variable modifications. Protein identifications 
were validated with at least two peptides with Mascot ion score above 20 or with one 
peptide with Mascot ion score above 30 and 5 consecutive fragment ions in MS/MS 
spectrum. 
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RESULTS AND DISCUSSION 
 
Nanoparticle characterisation in culture medium 
 
Upon sonication, copper and copper oxide nanoparticles could be dispersed to a 
microaggregate size of ca. 250 nm. These microaggregates were stable upon dilution in 
pure water, but we observed an immediate aggregation over the micron size when the 
nanoparticles were diluted in culture medium, even when containing fetal bovine serum. 
Unfortunately, this aggregation resulted in immediate sedimentation, leading to a very 
uneven exposure of the cell layer to the particles in the cell culture dish.  
All of the undesirable phenomena were prevented when the copper and copper oxide 
nanoparticles were coated with polyvinylpyrrolidone (PVP) prior to dilution in the cell culture 
medium. PVP has been used in the preparation of stable copper nanoparticles by aqueous 
routes (52-54), e.g., for conductive inks (55). PVP is also used for the stabilisation of silver 
nanoparticles (56, 57) and in commercial nanoparticle dispersions (e.g., silver nanoparticles 
from Buhler). It is also classified as a biocompatible polymer (58, 59) and does not activate 
the macrophages by itself (60). Indeed, it induced no biological response, neither in our 
proteomic experiments nor in the targeted ones (data not shown). 
Light scattering and scanning electron microscopy experiments showed that coating 
with PVP did not significantly change the microaggregation in water. However, the 
macroaggregation observed in culture media for noncoated particles was prevented, and 
the average diameter was kept close to 250 nm (Figure 1). The coating process with PVP 
significantly changed the zeta potential, measured at 0 mV instead of the classical 30 mV of 
a water suspension of CuO (61).  
 
Zirconium oxide nanoparticles had the same aggregation property in culture media, 
which was prevented as well by PVP coating. The resulting average size was 180 nm 
measured by light scattering.  
Dissolution studies, carried out in complete cell culture medium and in conditioned 
cell culture medium (both without cells), revealed that ca. 60% of the copper present initially 
in the nanoparticles was dissolved in the culture medium, and that dissolution was linear in 
the 5–20 µg/ml range. The dissolution data were similar whether fresh or conditioned 
medium was used and whether uncoated or PVP-coated nanoparticles were used. These 
dissolution figures are quite close to those reported recently under the same conditions, i.e., 
dispersion in water then dilution in complete cell culture medium (31).  
 
Determination of the effective copper doses 
 
For carrying out a proteomics study, it was necessary to determine the dose to obtain the 
best compromise between viability and biological effect. We, therefore, decided to use an 
LD20, which is a dose leading to a cell mortality of 20%, knowing that the mortality of the 
control culture is approximately 5%. As nanoparticles are known to interfere with many 
viability estimation methods (62), we chose a very conservative and robust dye exclusion 
method for this critical step (63).  
The results show that the LD20 was obtained at 10 µg/ml for the Cu and CuO 
nanoparticles for the RAW264 cell line, while it was obtained at 5 µg/ml for primary 
macrophages (Figure 2). A copper ion concentration of 0.2 mM corresponded to the LD20 
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for primary macrophages, while it induced no more than 10% mortality for the cell lines.  
We, therefore, fixed our working concentrations at LD20 for the nanoparticles and at 
0.2 mM for the copper ions.  
 
Determination of nanoparticle fate in cells 
 
In order to determine the fate of the nanoparticles in the presence of macrophages, 
transmission electron microscopy was performed on ultrathin sections of cells. These 
experiments showed that nanoparticles were present in vacuolar structures that were 
identified as multivesicular bodies and as lysosomes (Figure 3). These results were 
completely in line with what can be expected from professional phagocytic cells, as 
macrophages are. Moreover, these results demonstrate that macrophages seem to ingest 
nanoparticle aggregates present in the culture medium and to break them down within the 
endosomes-lysosomes. The first step was obviously the disaggregation of the aggregates 
into the nominal nanoparticles. However, the disaggregation did not seem to stop at this 
stage, as much smaller copper oxide particles were present (Figure 3). This observation is 
consistent with an intracellular dissolution of the copper oxide nanoparticles, which could be 
expected in an acidic organelle such as the lysosome. Macrophages are known to be able 
to uncoat nanoparticles (17), and this is further confirmed in our case by the existence of 
eroded nanoparticles within the cells. This size distribution was observed at both 4 hours 
and 24 hours of treatment with the nanoparticles. Thus, it can be concluded that the 
intracellular solubilisation of nanoparticles, which seems important for their biological effects 
(64), is kept even with coated nanoparticles. Overall, the coating process does not seem to 
interfere either with the extracellular or with the intracellular processes.  
 
 
Proteomic analyses 
 
The proteomic analyses were carried out on the RAW264 cell line, and typical gels are 
shown in Figure 4. More than 1,400 reliable spots were detected by the image analysis 
software, and they were further analysed for quantitative variations.  As for all omics 
strategies, the issue of multiple testing must be taken into account. In other terms, positive 
hits will always be obtained when many molecules are screened simultaneously, as in many 
comparative omic screens, just because of the statistical noise. Most classical statistical 
corrections for multiple testing, such as the Bonferroni correction, are not suited to omics 
data, where relatively low replicate numbers are available, and are in fact much too 
conservative (65). We, therefore, used the t-test distribution approach, pioneered by Storey 
and Tibshirani (48) for transcriptomics and first applied to proteomics by Karp and 
coworkers (49). The distribution of the p-values (t-test) for the three tested conditions 
(nanoparticular Cu, nanoparticular CuO and Cu ion) is shown in Supplementary figure 1. 
This approach showed us that we could not expect any really significant result with a 25-µM 
dose of copper ion, which has no effect on the cells. However, significant results could be 
expected for a higher dose of copper ion, corresponding to the LD20, as well as for copper 
and even more for copper oxide nanoparticles at the LD20.  
We, therefore, focused our analysis on spots that showed a consistent variation 
between the Cu and CuO treatment, and these spots are indicated in Figure 4. These spots 
were then identified by mass spectrometry, and the results are shown in Table 1, with more 
details in Supplementary Tables 1 and 2. Some neighbouring spots or spots corresponding 
to other proteins of interest were also identified.  On a global level, in addition to the 
classical metabolic modulation (66, 67), some cellular compartments/functions were 
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highlighted by this proteomic analysis, such as cytoskeleton, cell signalling, mitochondrion 
and oxidative stress response, especially in the glutathione system. 
In order to check for the specificity of the proteomic variations observed, we used 
zirconium oxide nanoparticles. These particles show very weak cytotoxicity (68) and were 
indeed nontoxic to RAW 264 cells up to 100 µg/ml. As the density of zirconium oxide (5.68) 
is close to that of copper oxide (6.31), it meant that treatment of the cells with an equal 
concentration in weight also corresponded to equal concentrations in particle numbers, 
which is an important parameter for phagocytic cells. Furthermore, as zirconium oxide 
nanoparticles are also dispersed with PVP, this control integrated any possible effect of 
absorbed PVP.  
Treatment with 10 µg/ml zirconium oxide for 24 hours induced very few changes 
detectable in our proteomic screen (Supplementary Table 3 and Supplementary Figure 2), 
and none of these changes corresponded to the ones induced by copper and copper oxide 
nanoparticles (Table 1). This showed the specificity of our proteomic results. We, therefore, 
decided to test specifically these functions by targeted analyses, both on the RAW 264 cell 
line and on primary macrophages derived from bone marrow. As the proteomic effects were 
more pronounced with CuO nanoparticles, we primarily used these nanoparticles for the 
targeted experiments; although some experiments were also carried out with copper 
nanoparticles. 
 
Characterisation of the general stress response 
 
Quite frequently, proteomic studies identify a general cellular stress response module, 
which encompasses proteins involved in central metabolism and protein production and 
folding (67).  However, in the case of the response of macrophages to copper-based 
nanoparticles, we did not observe the classical induction in central metabolism proteins. In 
contrast, we observed a small decrease in malate dehydrogenase, galactokinase and 
lactate dehydrogenase. We also did not observe changes in the heat shock proteins, in 
contrast to what has been described at the mRNA level in lung cells exposed to copper 
oxide nanoparticles (31), or at the protein level for cells exposed to gold nanoparticles (69). 
However, and consistent with the latter publication, we also observed a strong induction of 
the ribosomal protein P0.  
 
Characterisation of the oxidative stress response 
 
Oxidative stress has been observed in many cell types and with many nanoparticles 
[reviewed for example in (70)]. However, cellular responses to oxidative stress are not well 
characterised.  The cellular oxidative stress response system is quite complex and involves 
several classes of enzymes, including catalases, peroxidases (including peroxiredoxins), 
superoxide dismutases and enzymes producing and using glutathione.  
Our proteomic screen revealed that the heme oxygenase was very strongly induced, 
with a complex pattern of modifications. For the more classically observed peroxiredoxins 
(66, 67), we could determine by using the BHP oxidation test (71) that the induced form of 
Prx1 is indeed the oxidized form, while the native form of Prx6 is induced in our 
experiments. Other peroxiredoxins, such as Prx2 and the mitochondrial Prx3, remained 
unchanged, as shown in Table 1. The induction of Prx1 in response to gold nanoparticles 
has been described recently (69), but the status of the other peroxiredoxins had not been 
investigated. In addition, Prx1 is known to be inducible by heavy metals, as is heme 
oxygenase (72).  
Furthermore, our results are consistent with those obtained for Prx6 with oxidative stress in 
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lung cells (73) and in myoblasts (74).  
As to the superoxide dismutases, we observed a decrease in the copper-zinc 
superoxide dismutase.  The response of copper-zinc superoxide dismutase seems to be 
variable, because either an increase (75), decrease (76) or no change (29) has been 
described in response to metallic nanoparticles. We also observed no change for the 
mitochondrial manganese superoxide dismutase, although an increase in manganese 
superoxide dismutase has been described at the mRNA level (not at the protein level) in 
lung cells exposed to copper oxide nanoparticles (31). 
Finally, as to the glutathione-dependent oxidative stress response system, we 
observed an increase in formyl glutathione hydrolase and a strong induction of the 
regulatory subunit of the glutamate-cysteine ligase, i.e., the activating subunit of the limiting 
enzyme in glutathione biosynthesis (77). This suggested that the cells responding to 
copper-based nanoparticles make a strong effort to increase their glutathione level, and we 
tested the intracellular levels of reduced glutathione by a chlorobimane conjugation test 
(37). Compared with the positive control represented with diethyl maleate, which destroys 
reduced glutathione by alkylation, copper ion and copper-based nanoparticles induced a 
more subtle effect (Figure 5). A subpopulation of cells with low levels of reduced glutathione 
was induced, especially by copper nanoparticles. However, most of the cells had normal 
reduced glutathione levels, so that the average for the whole cell population was not 
significantly changed in most cases. In addition, the glutathione reductase was not induced 
by copper treatment (Figure 5).  
Primary macrophages, however, were more sensitive and showed a decrease in their 
free glutahione levels of copper ions and of the two-copper-based nanoparticles. These 
results were consistent with those observed previously with copper oxide nanoparticles in 
lung cells (29, 30) and with silver in liver cells (75, 78). In the case of copper-based 
nanoparticles, this is also consistent with the well-known role of glutathione as a copper 
buffer in cells (79). Consistent with this role, the decrease in free glutathione levels was also 
observed when the cells were treated with copper ions.  
However, the RAW264.7 cells appeared less sensitive to copper oxide and copper 
ions, as if the strong induction of glutamate-cysteine ligase was sufficient in this case to 
restore close to normal reduced glutathione levels. To verify this hypothesis, we treated 
RAW264.7 cells with non toxic doses of buthionine sulfoximine, an inhibitor of glutamate-
cysteine ligase. This induced a marked hypersensitivity of the cells to copper-based 
nanoparticles, as shown on Figure 5 (panel F) 
Overall, these proteomics-based results show the fine tuning of the cellular response 
to oxidative stress, as exemplified from the differential response of the three cytosolic 
peroxidoxins (Prx1, 2 and 6), and from the response of the glutathione-dependent system.  
 
Characterisation of the mitochondrial response 
 
Mitochondrial function is sometimes tested in response to nanoparticle exposure by testing 
the main parameter of mitochondrial transmembrane potential. A decrease in mitochondrial 
transmembrane potential has been observed in response to copper-based nanoparticles or 
to copper ions in liver (78), in  lung cells (80) and in macrophages (81). We also observed 
such a decrease in our study using a Rhodamine 123 uptake test (39), as shown in Figure 
6. Both nanoparticles and copper ions induced a dose-dependent decrease in the 
mitochondrial transmembrane potential, and this effect was more pronounced in the primary 
macrophages than in the cell line.  
Little is known, however, about the molecular events that could be related to the 
observed decrease in the mitochondrial transmembrane potential, which could even be due 
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to a change in the plasma membrane potential. However, our proteomics screen suggested 
some possible mechanisms. First of all, we did not observe any change in the two major 
mitochondrial antioxidant proteins, superoxide dismutase 2 and peroxiredoxin 3. This 
suggests that there is no massive mitochondrial oxidative stress. However, we observed an 
increase in the levels of mit-EF-Tu. As this protein is a translation factor for the 
intramitochondrial synthesis of the few respiratory chain proteins encoded by the 
mitochondrial genome, this result suggested an increase in the synthesis of the proteins of 
the oxidative phosphorylation chain, corroborated by an increase in one nuclear-coded 
subunit of the NADH dehydrogenase and one of the ubiquinol-cytochrome c oxidoreductase 
complex. However, the synthesis of another subunit of NADH dehydrogenase containing an 
iron-sulfur cluster (Ndufs8) was decreased. This suggests a toxic mechanism in which 
copper ions pumped into the mitochondria may alter the function of redox-sensitive proteins 
containing iron-sulfur clusters and, thus, alter both electron transfer and proton pumping 
through the inner mitochondrial membrane, leading to the observed decrease in the 
transmembrane potential. In this context, the observed increases in mit-EF-Tu, Uqcrc1 and 
Ndufs3 would represent an attempt of the cells to restore a normal mitochondrial 
transmembrane potential, which is observed at nontoxic doses of nanoparticles in RAW 264 
cells. In order to test this hypothesis, we analysed cell survival after treatment with subtoxic 
doses of inhibitors targeting the two respiratory complexes highlighted by proteomics, 
namely Complex I and Complex III, inhibited respectively by rotenone and antimycin A. The 
results show the synergistic toxicity of mitochondrial inhibitors and copper oxide 
nanoparticles (Figure 6).  
 
Changes in the cytoskeleton, intracellular trafficking and phagocytosis 
 
Our proteomic screen pointed to changes in the cytoskeleton induced by copper-based 
nanoparticles. However, not all types of cytoskeletal proteins were altered by the 
nanoparticles. The tubulin cytoskeleton did not show any change in our screen, and besides 
vimentin, mostly the actin-myosin cytoskeleton was altered, either directly (decrease in 
tropomyosins) or indirectly (decrease in Rho GDI inhibitors, which is functionally equivalent 
to an increase in the activity of the Rho proteins).  Rho proteins control specific modulations 
of the actin cytoskeleton (e.g., formation of stress fibres) that have been associated with 
decreased phagocytic capacity in macrophages stressed by hyperoxia (82).  
A decrease in a subunit of the proton pump also pointed to a possible phagocytic 
deficiency. This prompted us to assay phagocytosis, which is a key macrophage function. 
CuO nanoparticles had no effect at moderately toxic doses in cell lines, and an inhibition of 
phagocytosis was apparent only at a toxic dose (20 µg/ml) (Figure 7). Cu nanoparticles 
were more efficient at inhibiting phagocytosis, while copper ions had no effect. In primary 
macrophages, which are more sensitive to nanoparticles in all our tests, both Cu and CuO 
nanoparticles were efficient in inhibiting phagocytosis, while Cu ions had no effect. 
Interestingly, tropomyosin, Rho GDI inhibitors and proton pump subunits were not 
modulated by copper ions in our proteomic screen.  
To further study the functional effects of the observed decrease in the proton pump, 
we performed a classical neutral red uptake assay. Although classically used as a general 
viability assay (35), neutral red uptake is indeed an assay of lysosomal function because the 
acidic conditions retain neutral red inside the lysosomes.  
Figure 7C shows that neutral red uptake decreases more severely upon treatment 
with copper oxide nanoparticles than should be expected from a simple decrease in cell 
viability, showing a specific effect on lysosomes and validating the proteomically observed 
decrease in the proton pump.  
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NO production 
 
In addition to phagocytosis, production of cytokines and of NO is a key function of 
macrophages. We, therefore, tested the production of NO in two different setups. In the first 
setup, we tested if nanoparticles could directly induce the production of NO, as this has 
been shown to occur with silver nanoparticles (13). In the second setup, we tested the 
modulation of the LPS-induced production of NO by a previous treatment with nanoparticles 
(Figure 8). While Cu-NP, CuO-NP and copper ions did not induce the production of NO by 
themselves, all three moderately inhibited LPS-induced NO production in primary 
macrophages. However, only copper ions were able to reduce the LPS-induced NO 
production in the case of the RAW 264 cell line. These results on NO production could be 
linked, at least indirectly, with the decrease in S-Adenosylhomocysteine hydrolase observed 
in our proteomic screen. Inhibition of S-Adenosylhomocysteine hydrolase has been shown 
to reduce pro-inflammatory properties (83), and this can be linked, at least in part to a 
decrease in adenosine concentrations, as adenosine is a potent activator of nitric oxide 
production in macrophages (84). Through this pathway, a reduced level of S-
Adenosylhomocysteine hydrolase would suggest a lower ability to produce NO, at least  in 
response to LPS, and this is exactly what was observed when NO production was 
specifically tested.  
 
 
Overall, what can be explained by copper ions in the toxicity of nanoparticles ?  
 
Since the demonstration of an important copper ion release from copper-based 
nanoparticles in biological media (85), it is generally thought that most of the nanoparticle 
toxicity arises from the copper ion itself, and not directly from the nanoparticles. However, 
transcriptomic studies (31), as well as our work presented here, show that extracellular 
copper ions can only account for a part of the cellular responses to copper-based 
nanoparticles. In our case, extracellular copper ions induced the general cellular stress 
responses (mitochondrial or glutathione dependent) and altered some specific cellular 
responses (e.g., nitric oxide production) but not all. For example, phagocytosis, a key 
function of macrophages,  is altered by the nanoparticles but not by the free ions. We could, 
however, rule out a mechanical explanation of this inhibition, as titanium dioxide 
nanoparticles do not inhibit phagocytosis (data not shown).  
These differences between the responses to the ion itself and to the nanoparticles 
may be the result of the existence of two different copper channels at the plasma membrane 
(Ctr1) and at the lysosomal membrane (Ctr2) (86). Thus, the real intracellular concentration, 
and even more subtly, the local copper concentrations within the cell can differ depending 
on the mode of entry. This might be the case for highly phagocytic cells such as 
macrophages, for which the lysosome-dependent entry can be much more important than 
the plasma membrane-dependent entry. 
 
Concluding remarks 
 
Despite its limited depth, estimated to ca. 500 proteins [1,500 spots for an average of 3 
spots per protein (87)] the proteomics screen used here allowed us to point out several 
cellular functions that were modified upon treatment of macrophages with copper-based 
nanoparticles and/or copper ions. Interestingly, copper treatment was associated with a 
reduction in protein levels, suggesting either a decrease in their synthesis or an increase in 
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their degradation. The fact that some copper-binding proteins (e.g., copper-zinc superoxide 
dismutase and S-adenosyl homocysteine hydrolase) diminished suggests that an excess in 
intracellular copper could lead to protein destructuration and then degradation.  
Moreover, the increase in the glutamate cysteine ligase subunit and of some 
mitochondrial proteins shows how proteomics can point to cellular resistance mechanisms 
even when they are successful, so that no apparent change can be detected in the 
downstream parameter (e.g., glutathione levels). 
In the frame of macrophage physiology, the uptake of copper does not bring an 
activation of the macrophages, with the associated increase in the production of 
inflammatory mediators, as described for SiO2 an TiO2 nanoparticles (4) (88). It rather 
brings a depression of core macrophage activities such as NO production and 
phagocytosis, which can have in turn consequences on the overall efficiency of the immune 
system.  
Finally, our results also show that even at nonlethal doses, nanoparticles can act 
synergistically with other toxicants to induce cell mortality and dysfunction.  
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Figure 1: Characterization of the nanoparticles after dispersion by sonication and coating 
with PVP-40.   
A: size distribution of copper nanoparticles after sonication, coating with PVP-40 and 
dilution in RPMI 1640 medium containing 10% fetal calf serum 
B: SEM of copper nanoparticles 
C: size distribution of copper oxide nanoparticles after sonication, coating with PVP-40 and 
dilution in RPMI 1640 medium containing 10% fetal calf serum 
D: SEM of copper oxide nanoparticles 
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Figure 2: Determination of the viability of the cells after treatment with copper nanoparticles, 
copper oxide nanoparticles, and copper(II) chloride.  
The viability was measured by trypan blue exclusion. 
A: RAW 264 cells 
B: primary macrophages derived from bone marrow 
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Figure 3: Transmission electron microscopy analysis of nanoparticles-treated cells 
RAW264 cells were images by transmission electron microscopy after treatment with copper 
oxide nanoparticles par 4 hours (panels A, C and D) and 24 hours (panel B). The copper 
nanoparticles are concentrated in multivesicular bodies and in lysosomes, as expected for 
professional phagocytic cells. Cells treated for 24 hours show much larger, fusioned 
lysosomes than cells treated for only 4 hours. Various sizes of copper oxide can be seen, 
from the 200-300 nm aggregates present in the medium (thick arrows) to the 30-50 nm of 
the initial (thin arrows) and even to smaller sizes such as 10 nm (arrowheads) as can be 
expected from the intracellular dissolution of the nanoparticles.  
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Figure 4: Proteomic analysis by 2D electrophoresis 
 
Part A 
Total cell extracts of RAW264 cells were separated by two-dimensional gel electrophoresis. 
The first dimensions covered a 4-8 pH range and the second dimension a 15-200 kDa 
range. Total cellular proteins (150 µg)  were loaded on the first dimension gel, and the spots 
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were detected by silver staining.  
A: gel obtained from control cells 
B: gel obtained from copper nanoparticles-treated cells 
C: gel obtained from copper oxide nanoparticles-treated cells 
 
The arrows point to spots that show reproducible and statistically significant changes 
between the control condition and the treatments with Cu or CuO nanoparticles. the 
numbering of the spots is explained on Table 1.  
Rectangles A to D point to areas with a high density of selected spots, shown on a different 
figure. Gels coming from cells treated with copper chloride have been omitted for clarity 
reasons 
 
Part B 
Insets from gels displayed on Part A, shown at a higher magnification for more clarity in spot 
pointing 
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Figure 5: Analysis of the glutathione-based antioxidant system 
 
This figure shows the variation of the intracellular levels of reduced glutathione, estimated 
through conjugation with monochlorobimane to form a fluorescent adduct and analysis by a 
MoFlo cell sorter. 
 
Top panel:  distribution of the MCB-GSH adduct fluorescence in control cells (A) and cells 
treated with diethyl maleate (B), which acts as a negative control by reacting with reduced 
glutathione before the cells are treated with monochlorobimane. This experiment allow to 
define the GSH-high and GSH-low cells by their fluorescence. 
 
Median panel: variation in the intracellular glutathione levels upon treatment with copper 
nanoparticles, copper oxide nanoparticles, or copper ion. Three independent experiments 
per condition 
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C : variation in the percentage of GSH high cells in RAW264 cells, showing the appearance 
of a population of GSH-low cells, especially in cells treated with copper nanoparticles. 
 
D: variation in the percentage of GSH high cells in primary macrophages, showing the 
appearance of a population of GSH-low cells, especially in cells treated with copper 
nanoparticles. 
 
E: variation in the glutathione reductase activity in RAW264 cells treated with copper oxide 
nanoparticles or with copper ion 
 
*: p<0.05; **:  p<0.01; ***:  p< 0.001 (Mann-Whitney test) 
 
F: cell viability upon inhibition of glutathione biosynthesis 
Control cells (white bars bars) or cells pre-treated with buthionine sulfoximine to inhibit 
glutathione biosynthesis grey bars) were treated with various doses of copepr oxide 
nanoparticles. Viability measured by trypan blue exclusion 
 
*: p<0.05; **:  p<0.01; ***:  p< 0.001 (Mann-Whitney test) 
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Figure 6: Analysis of the mitochondrial function 
 
The top two panels of this figure show the amount of rhodamine internalized in the cells, 
expressed in percentage of the fluorescence in control cells (3 independent experiments). 
Fluorescence measurements were carried out on a FACScalibur cell sorter.  
A: results obtained with  RAW264 cells 
B: results obtained with primary macrophages derived from bone marrow 
 
*: p<0.05; **:  p<0.01 (Mann-Whitney test) 
 
C: cell survival after treatment with inhibitors of the mitochondrial respiratory chain and 
subsequent treatment with copper oxide nanoparticles. 
white bars: control cells; grey bars: cells treated with 200nm rotenone; black bars: cells 
treated with 200nm antimycin A 
 
*: p<0.05; **:  p<0.01; ***:  p<0.001 (Student T- test) 
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Figure 7: Analysis of the phagocytic capacity 
 
This figure shows the determination of the phagocytic properties of the cells, through 
ingestion of fluorescent beads and analysis with a FACScalibur cell sorter. 
 
Top panel: distribution of the fluorescence of the cells, showing the negative cells (control at 
4°C) and the positive cells (control at 37°C), as well as the raw data obtained for cells 
treated with copper oxide nanoparticles for 24 hours prior to treatment with the fluorescent 
beads 
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Median panel: variation of the phagocytic capacity of the cells under different conditions, 
expressed in percentage of the control cells. Three independent experiments 
A: results obtained with RAW264 cells 
B:  results obtained with primary macrophages derived from bone marrow (one experiment 
only for copper nanoparticles) 
The results show the strong effect of copper and copper oxide nanoparticles on the 
phagocytic capacity of the cells, and the absence of effect of the copper ion. 
 
*: p<0.05; **:  p<0.01 (Mann-Whitney test) 
 
Bottom panel 
C: comparative variation of cell viability and neutral red uptake capacity.  
This figure shows that the lysosomal functionality of the cells is altered by the copper oxide 
nanoparticles (but not the ion), as the neutral red uptake decreases more steeply than the 
overall cell viability.  
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Figure 8: analysis of the nitrous oxide production 
 
This figures shows the amount of NO produced by the cells. White bars: without secondary 
treatment with LPS. Black bars: with secondary treatment with LPS 
 
A: RAW264 cells 
B: Primary macrophages derived from bone marrow 
*: p<0.05; **:  p<0.01 (Mann-Whitney test)1. 
 
 
 34 
 
Table 1: Differentially-expressed proteins identified in the proteomic screen 
 
Spot 
number 
Protein name 
Protein 
accession 
numbers 
Protein 
molecular 
weight (Da) 
Cu/ctrl 
(ratio/p 
value) 
CuO/ctrl 
(ratio/p 
value) 
Cu2+/ctrl 
(ratio/pva
lue) 
ZrO2/ctrl 
(ratio/p 
value) 
Number of 
unique 
peptides 
         
 Oxidative stress        
1 Superoxide dismutase [Cu-Zn]  P08228 15924 0.40/0.08 0.33 / 0.05 1.09/0.72 0.824/0.06 7 
2 Peroxiredoxin-6  O08709 24854 0.91/0.42 0.75/0.04 0.91/0.55 1.016/0.64 5 
3 Peroxiredoxin-1  P35700 22160 2.8/0.04 3.3/0.03 1.0/1.0 1.17/0.21 6 
4 Peroxiredoxin-1  P35700 22160 1.28/0.21 2.1/0.002 1.56/0.01 0.921/0.25 7 
5 Heme oxygenase 1  P14901 32911 3.8/0.05 3.8/0.02 0.81/0.52 0805/0.82 1 
6 Heme oxygenase 1  P14901 32911 1.47/0.12 1.61/0.02 1.00/0.97 0.732/0.25 2 
7 Heme oxygenase 1  P14901 32911 3.2/0.05 1.49/0.23 5.35/0.02  2 
8 Heme oxygenase 1  P14901 32911 1.96/0.001 1.93/0.02 2.25/0.04 1.265/0.05 4 
9 Heme oxygenase 1  P14901 32911 1.7/0.22 2.1/0.11 1.16/0.75 1.049/0.70 1 
10 S-formylglutathione hydrolase  Q9R0P3 31302 1.47/0.03 1.84/0.03 1.23/0.41 0.958/0.70 2 
11 
Glutamate--cysteine ligase 
regulatory subunit  
O09172 30517 1.3/0.04 1.35/0.01 2.38/0.002 0.929/0.15 3 
         
 Mitochondrion        
12 
NADH dehydrogenase iron-
sulfur protein 8, mitochondrial  
Q8K3J1 24039 0.97/0.6 0.6/0.002 0.98/0.96 0.89/0.14 8 
13 
NADH dehydrogenase iron-
sulfur protein 3, mitochondrial  
Q9DCT2 30131 1.55/0.03 1.1/0.5 0.8/0.15 0.86/0.06 4 
14 
Cytochrome b-c1 complex 
subunit 1, mitochondrial  
Q9CZ13 52834 1.4/0.005 1.4/0.007 0.72/0.11 1.142/0.21 6 
15 
Elongation factor Tu, 
mitochondrial  
Q8BFR5 49491 1.3/0.27 1.6/0.05 1.16/0.31 0.797/0.06 3 
16 
Glutamate dehydrogenase 1, 
mitochondrial  
P26443 61320 1.016/0.92 1.345/0.1 1.1/0.56 0.99/0.88 2 
17 
Glutamate dehydrogenase 1, 
mitochondrial  
P26443 61320 1.32/0.01 1.44/0.04 0.77/0.19 1.095/0.82 2 
         
 Cell signalling        
18 
Rho GDP-dissociation inhibitor 
2  
Q61599 22833 0.73/0.02 0.70/0.01 1.048/0.74 0.973/0.48 3 
19 
Rho GDP-dissociation inhibitor 
2  
Q61599 22833 0.77/0.25 0.606/0.07 0.94/0.8 0.902/0.02 3 
20 
Rho GDP-dissociation inhibitor 
1  
Q99PT1 23390 0.67/0.004 0.73/0.04 0.70/0.09 0.947/0.50 4 
21 
Rho GDP-dissociation inhibitor 
1  
Q99PT1 23390 081/0.07 0.78/0.02 0.95/0.54 0.977/0.40 7 
22 Inositol monophosphatase 1  O55023 30437 0.66/0.003 0.67/0.01 0.97/0.74 1.065/0.46 8 
23 14-3-3 protein zeta/delta  P63101 27772 0.67/0.06 0.4/0.05 0.80/0.25 0.933/0.16 10 
24 14-3-3 protein beta/alpha  Q9CQV8 28069 0.77/0.11 0.66/0.04 0.84/0.55 0.971/0.80 2 
25 14-3-3 protein gamma  P61982 28285 
0.805/0.00
4 
0.77/0.06 0.74/0.60 1.088/0.42 5 
26 14-3-3 protein gamma  P61982 28285 0.77/0.2 0.49/0.015 0.88/0.66 1.09/0.32 7 
27 14-3-3 protein beta/alpha  Q9CQV8 28069 0.89/0.45 0.91/0.67 0.91/0.68 0.889/0.25 4 
28 
Guanine nucleotide-binding 
protein G(i) subunit alpha-2  
P08752 40472 0.6/0.01 0.55/0.005 0.89/0.23 0.882/0.50 4 
29 
Guanine nucleotide-binding 
protein G(i) subunit alpha-2  
P08752 40472 0.8/0.06 0.78/0.11 0.88/0.29 .0924/0.32 5 
30 
Serine-threonine kinase 
receptor-associated protein  
Q9Z1Z2 38425 0.75/0.02 0.65/0.01 0.98/0.94 0.946/0.52 4 
         
 Central metabolism        
31 
Malate dehydrogenase, 
cytoplasmic  
P14152 36512 0.61/0.045 0.62/0.01 0.9/0.53 0.906/0.19 5 
32 Malate dehydrogenase, P14152 36512 0.79/0.2 0.63/0.03 1.077/0.61 0.88/0.11 9 
 35 
cytoplasmic  
33 Alpha-enolase  P17182 47124 0.96/0.65 0.82/0.05 0.87/0.54 0.76/0.08 3 
34 Alpha-enolase  P17182 47124 0.9/0.3 0.8/0.05 0.85/0.36 0.942/0.64 3 
35 Galactokinase  Q9R0N0 42158 0.77/0.015 0.5/0.001 0.91/0.33 1.011/0.85 5 
36 L-lactate dehydrogenase A chain  P06151 36481 0.8/0.03 0.85/0.11 0.80.01 1.066/0.23 7 
         
 Protein production and folding      
37 
Eukaryotic translation initiation 
factor 5A-1  
P63242 16815 0.84/0.2 0.43/0.01 1.07/0.50 0.874/0.14 2 
38 Elongation factor 1-beta  O70251 24676 0.7/0.06 0.5/0.015 0.7/0.45 1.023/0.87 5 
39 Elongation factor 1-beta  O70251 24676 1.1/0.57 0.8/0.5 0.66/0.45 1.14/0.23 2 
40 Elongation factor 1-delta  P57776 31275 0.70/0.07 0.48/0.01 1.033/0.93 1.167/0.21 4 
41 Elongation factor 1-delta  P57776 31275 0.79/0.16 0.7/0.1 0.97/0.94 1.059/0.27 4 
42 60S acidic ribosomal protein P0  P14869 34256 1.98/0.05 2.3/0.001 2.6/0.007 0.814/0.27 2 
43 
Endoplasmic reticulum resident 
protein 29  
P57759 28807 1.33/0.08 1.78/0.01 0.88/0.46 0.875/0.80 5 
44 
Peptidyl-prolyl cis-trans 
isomerase A  
P17742 17954 0.66/0.23 0.5/0.02 1.23/0.57 0.828/0.20 2 
45 
Peptidyl-prolyl cis-trans 
isomerase A 
P17742 17954 0.5/0.03 0.65/0.15 0.88/0.34 0.993/0.92 1 
         
 Cytoskeleton and intracellular traffic      
46 Tropomyosin alpha-3 chain  Q63610 28989 0.5/0.07 0.45/0.05 0.87/0.30 1.15/0.24 6 
47 Tropomyosin alpha-3 chain  Q63610 28989 0.84/0.49 0.825/0.45 1.03/0.67 0.845/0.03 12 
48 Vimentin  P20152 53671 0.9/0.22 0.77/0.05 0643/0.13 0.944/0.40 8 
49 V-type proton ATPase subunit H  Q8BVE3 55838 0.77/0.09 0.69/0.01 1.054/0.80 0.835/0.12 2 
50 
Transmembrane emp24 domain-
containing protein 2  
Q9R0Q3 22687 1.55/0.04 1.6/0.01 1.13/0.77 1.135/0.26 3 
         
 Miscellaneous        
51 
Chloride intracellular channel 
protein 1  
Q9Z1Q5 26996 0.79/0.09 0.71/0.03 1.09/0.58 0.85/0.14 4 
52 
Chloride intracellular channel 
protein 1  
Q9Z1Q5 26996 0.86/0.23 0.7/0.03 0.98/0.57 0.982/0.61 5 
53 
EF-hand domain-containing 
protein D2  
Q4FZY0 26742 0.87/0.21 0.69/0.008 1.025/0.84 1.038/0.62 2 
54 Proliferating cell nuclear antigen  P17918 28768 0.75/0.06 0.66/0.02 0.99/0.95 0.984/0.85 2 
55 
Farnesyl pyrophosphate 
synthase  
Q920E5 40565 0.8/0.001 0.8/0.04 0.8/0.14 0.984/0.87 2 
56 Poly(rC)-binding protein 1 O19048 37480 0.76/0.02 0.79/0.003 1.2/0.24 1.084/0.46 1 
58 Ubiquitin thioesterase OTUB1  Q7TQI3 31253 0.77/0.04 0.66/0.04 1.02/0.83 1.015/0.80 2 
59 Adenosylhomocysteinase  P50247 47671 0.47/0.004 0.65/0.02 0.9/0.51 0.958/0.47 11 
60 Adenosylhomocysteinase  P50247 47671 0.77/0.01 0.78/0.008 1.14/0.03 1.056/0.65 21 
         
 Other proteins        
61 
Peptidyl-prolyl cis-trans 
isomerase A  
P17742 17954 0.75/0.15 0.78/0.18 1.012/0.95 
0.981/0.74 
13 
62 
Superoxide dismutase [Mn], 
mitochondrial  
P09671 24585 1.17/0.22 1.08/0.75 0.38/0.11 1.347/0.53 4 
63 Peroxiredoxin-2  Q61171 21761 0.92/0.62 0.70/0.23 1.03/0.72 1.02/0.73 7 
64 Peroxiredoxin-3 P20108 28109 1.41/0.10 1.30/0.22 1.13/0.12 0.976/0.73 6 
65 Ferritin light chain 1  P29391 20785 1.29/0.09 1.31/0.25 1.62/0.025 1.18/0.05 9 
66 
Eukaryotic initiation factor 4A-
III  
P38919 46824 1.046/0.75 1.13/0.38 0.97/0.88 0.933/0.55 20 
67 Elongation factor 1-gamma  Q9D8N0 50043 1.004/0.98 0.952/0.73 1.0/0.99 0.964/0.65 16 
 
 
*The accession numbers are those of the SwissProt Database.  
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